$Profound Medical(PROF.US)$ NEWS Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum Profound Medical Corp.'s TULSA procedure is gaining recognition as a mainstream treatment for prostate diseases, with 25 scientific research presentations this year alone. The clinical evidence showcases TULSA's efficacy in treating a diverse range of patients with localized prostate c...
Profound Medical股票讨论
Profound Medical 宣布塔尔萨治疗前列腺疾病的 1 类 CPT 守则提出 CY2025 规则
Profound Medical宣布，美国医疗保险和医疗补助服务中心（CMS）提出了经尿道超声消融术（TULSA）的1类CPT代码，自2025年1月1日起生效。这包括适用于不同手术场景的三种医生守则，为术前和术后就诊带来了更大的计费灵活性。
塔尔萨将被认可...
NEWS
Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum
Profound Medical Corp.'s TULSA procedure is gaining recognition as a mainstream treatment for prostate diseases, with 25 scientific research presentations this year alone. The clinical evidence showcases TULSA's efficacy in treating a diverse range of patients with localized prostate c...
暂无评论